|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
level in the ischemic-reperfused heart
1 Department of Physiology, Faculty of Medicine, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Center, University of Manitoba, Winnipeg, Manitoba, Canada
2 Division of Cardiology, Heart and Stroke/Richard Lewar Centre of Excellence, University of Toronto, Toronto, Ontario, Canada
* To whom correspondence should be addressed. E-mail: nsdhalla{at}sbrc.ca.
Although pentoxifylline (PTXF), a phosphodiesterase inhibitor, has been reported to exert beneficial effects in cardiac bypass surgery, its effect and mechanisms against ischemia-reperfusion (I/R) injury in the heart are poorly understood. Since I/R is known to increase the level of tumor necrosis factor-alpha (TNF-
) in the myocardium and PTXF has been shown to depress the production of TNF-
in the failing heart, this study examined the hypothesis that PTXF may attenuate cardiac dysfunction and reduce TNF-
content in the I/R heart. For this purpose, isolated rat hearts were subjected to global ischemia for 30 min followed by reperfusion for 2 to 30 min. While cardiac dysfunction due to ischemia was not affected, the recovery of heart function upon reperfusion was markedly improved by PTXF treatment. This cardioprotective effect of PTXF was dose-dependent; maximal effect was seen at a concentration of 125 µM. TNF-
, nuclear factor kappa B (NF
B) and phosphophorylated NF
B contents, were decreased in the ischemic heart but were markedly increased within 2 min of starting reperfusion. The ratio of cytosolic to homogenate NF
B was decreased whereas that for particulate to homogenate NF
B was increased in the I/R hearts. These changes in TNF-
and NF
B protein contents, as well as in NF
B redistribution due to I/R, were significantly attenuated by PTXF treatment. The results in this study indicate that the cardioprotective effects of PTXF against I/R injury may be due to reduction in the activation of NF
B and the production of TNF-
content.
This article has been cited by other articles:
![]() |
M. H. Rosner, D. Portilla, and M. D. Okusa Analytic Reviews: Cardiac Surgery as a Cause of Acute Kidney Injury: Pathogenesis and Potential Therapies J Intensive Care Med, January 1, 2008; 23(1): 3 - 18. [Abstract] [PDF] |
||||
![]() |
N. Mariappan, R. N. Soorappan, M. Haque, S. Sriramula, and J. Francis TNF-{alpha}-induced mitochondrial oxidative stress and cardiac dysfunction: restoration by superoxide dismutase mimetic Tempol Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H2726 - H2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Guggilam, M. Haque, E. K. Kerut, E. McIlwain, P. Lucchesi, I. Seghal, and J. Francis TNF-{alpha} blockade decreases oxidative stress in the paraventricular nucleus and attenuates sympathoexcitation in heart failure rats Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H599 - H609. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Rosner and M. D. Okusa Acute Kidney Injury Associated with Cardiac Surgery Clin. J. Am. Soc. Nephrol., January 1, 2006; 1(1): 19 - 32. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |